Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GI
| Image |  |
|---|---|
| Description | scientific article published on 17 April 2019 |
| Author/s |
author: Paolo Marchetti Michelino De Laurentiis Corrado Ficorella Daniele Santini Patrizia Vici |
| Publication date | April 17, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |